Midcap Stocks Research: Subscribe for 1 Year... Get Access for 3 Years
Here is the latest financial fact sheet of SAROJA PHARMA INDUSTRIES INDIA LTD.. For more details, see the SAROJA PHARMA INDUSTRIES INDIA LTD. quarterly results and SAROJA PHARMA INDUSTRIES INDIA LTD. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.0 |
No. of shares | m | 4.02 |
1 Week | % | -5.9 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 82.9/35.0 |
No. of Mths Year Ending |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SAROJA PHARMA INDUSTRIES INDIA LTD. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | |||
Low | Rs | NA | NA | NA | |||
Sales per share (Unadj.) | Rs | 36,662.0 | 2,418.8 | 170.7 | |||
Earnings per share (Unadj.) | Rs | 731.0 | 49.6 | 3.6 | |||
Diluted earnings per share | Rs | 1.8 | 2.8 | 2.6 | |||
Cash flow per share (Unadj.) | Rs | 754.0 | 51.6 | 3.8 | |||
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | |||
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | |||
Avg Dividend yield | % | 0 | 0 | 0 | |||
Book value per share (Unadj.) | Rs | 936.0 | 175.0 | 17.3 | |||
Adj. book value per share | Rs | 2.3 | 10.0 | 12.7 | |||
Shares outstanding (eoy) | m | 0.01 | 0.23 | 2.94 | |||
Price / Sales ratio | x | 0 | 0 | 0 | |||
Avg P/E ratio | x | 0 | 0 | 0 | |||
P/CF ratio (eoy) | x | 0 | 0 | 0 | |||
Price / Book Value ratio | x | 0 | 0 | 0 | |||
Dividend payout | % | 0 | 0 | 0 | |||
Avg Mkt Cap | Rs m | 0 | 0 | 0 | |||
Total wages/salary | Rs m | 5 | 7 | 8 |
SAROJA PHARMA INDUSTRIES INDIA LTD. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 367 | 556 | 502 | |||
Other income | Rs m | 1 | 3 | 2 | |||
Total revenues | Rs m | 367 | 560 | 504 | |||
Gross profit | Rs m | 13 | 21 | 27 | |||
Depreciation | Rs m | 0 | 0 | 1 | |||
Interest | Rs m | 3 | 8 | 13 | |||
Profit before tax | Rs m | 10 | 16 | 15 | |||
Minority Interest | Rs m | 0 | 0 | 0 | |||
Prior Period Items | Rs m | 0 | 0 | 0 | |||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | |||
Tax | Rs m | 3 | 4 | 4 | |||
Profit after tax | Rs m | 7 | 11 | 11 | |||
Gross profit margin | % | 3.6 | 3.8 | 5.4 | |||
Effective tax rate | % | 29.4 | 27.8 | 28.9 | |||
Net profit margin | % | 2.0 | 2.0 | 2.1 |
SAROJA PHARMA INDUSTRIES INDIA LTD. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 81 | 151 | 161 | |||
Current liabilities | Rs m | 59 | 98 | 134 | |||
Net working cap to sales | % | 6.1 | 9.5 | 5.4 | |||
Current ratio | x | 1.4 | 1.5 | 1.2 | |||
Inventory Days | Days | 0 | 0 | 9 | |||
Debtors Days | Days | 719 | 917 | 808 | |||
Net fixed assets | Rs m | 1 | 4 | 52 | |||
Share capital | Rs m | 0 | 2 | 29 | |||
"Free" reserves | Rs m | 9 | 38 | 22 | |||
Net worth | Rs m | 9 | 40 | 51 | |||
Long term debt | Rs m | 14 | 17 | 28 | |||
Total assets | Rs m | 82 | 155 | 213 | |||
Interest coverage | x | 4.1 | 3.0 | 2.1 | |||
Debt to equity ratio | x | 1.5 | 0.4 | 0.6 | |||
Sales to assets ratio | x | 4.5 | 3.6 | 2.4 | |||
Return on assets | % | 12.9 | 12.5 | 11.2 | |||
Return on equity | % | 78.1 | 28.3 | 20.8 | |||
Return on capital | % | 58.1 | 41.6 | 35.6 | |||
Exports to sales | % | 0 | 0 | 0 | |||
Imports to sales | % | 0 | 0 | 0 | |||
Exports (fob) | Rs m | 0 | 0 | 0 | |||
Imports (cif) | Rs m | 0 | 0 | 0 | |||
Fx inflow | Rs m | 54 | 122 | 47 | |||
Fx outflow | Rs m | 1 | 1 | 0 | |||
Net fx | Rs m | 53 | 121 | 47 |
SAROJA PHARMA INDUSTRIES INDIA LTD. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -10 | -37 | 22 | |||
From Investments | Rs m | -1 | -3 | -48 | |||
From Financial Activity | Rs m | 10 | 43 | 27 | |||
Net Cashflow | Rs m | -1 | 3 | 1 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Biju Nair | COMP SEC: Nikita Kumar | YEAR OF INC: 2019 | NSE CODE: 99307 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare SAROJA PHARMA INDUSTRIES INDIA LTD. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Indian share markets Slipped further as the session progressed and ended the day weak.